Objectives/setting: The effectiveness of screening programmes may be improved by knowledge of factors affecting screening uptake, disease prevalence and attendance for follow-up. Data from the Multicentre Aneurysm Screening Study (MASS) are used to examine the influences of age and social deprivation in the context of screening for abdominal aortic aneurysms (AAAs).
U ltrasoun d screening can be used to measure the aorta in 99°/~of indi.viduals, I.2 enabling early detection of abdominal aortic aneurysms (AAAs).1.3-8 Because the age-standardised prevalence of AAA is considerably higher in men than women, systematic screening is generally recommended only for men in the UK. 9 The Multicentre Aneurysm Screening Study (MASS) provided strong evidence for both the clinical benefit of screening? and its cost-effectiveness" for men in the UK. In MASS, a population-based sample of 68,000 men was randomised to either a control group receiving no intervention or to a group invited to attend ultrasound screening for early detection of AAA. Of the 34,000 men invited, 80% attended for screening. By intention-to-treat analysis, a risk reduction of 42% (95% confidence interval [CI] 22-58%, p=0.0002) in AAA-related mortality over four years was observed in the invited-to-screening group. The benefit was even greater amongst those who actually attended screening, with a risk reduction of 53% (95% CI 30-64%).
One route to maximising the benefit from a screening programme for AAA is to optimise attendance, by targeting groups identified as less likely to attend screening. Other studies of attendance at screening programmes, both for AAA and for various cancers.";" have identified relevant factors, including socioeconomic status lO,I2,I7,I9 and education.!':":" martial status,IO,II,16-18 measures of self-assessed health.!':" age,IO,II.IS-18 ethnicity.!":" smoking'<"-" and distance from the screening clinic. IO,13,14,16 However, a recent systematic review" has shown that for many of these, particularly age, studies report conflicting results with regard to the direction of any association with attendance. Identification of groups less likely to attend AAA screening is particularly important, because some of these groups are at increased risk of having an AAA. 8,IO,lS,2G-22 Attending for clinical follow-up (recall scans and referral for elective surgery) is also important if the full benefit of the screening programme is to be realised. ' In this study, attendance at screening, prevalence of AAA amongst attenders, and attendance at recall scans amongst those with a detected AAA, are investigated. Each of these outcomes is analysed in terms of age at randomisation and social deprivation, as well as season of the year when invited to attend for initial screening.
METHODS
The MASS trial recruited men aged 65 to 74 in four regional centres in the UK (Portsmouth, Winchester, Southampton and Oxford). In brief.' 67,800 men were randomised, of whom 33,839 were invited to attend for ultrasound screening. Attenders from the first-and second-round invitations were combined because attending after re-invitation accounted for only 4% of all attenders. An AAA was defined as an aortic diameter of 30mm or larger. Follow-up for those with a detected aneurysm continued for an average of four years, with recall scans at three-or 12-month intervals depending on aneurysm size, and referral for consideration www.jmedscreen.com Uptake of AAA screening of elective surgery occurred when the aneurysm diameter exceeded 55mm. Nonattendance at recall was defined as nonattendance at any subsequent recall scan (excluding rearranged appointments) following detection of an AAA.
Statistical analysis
The associations of attendance at screening with age at randomisation, social deprivation and season when invited to attend were investigated using logistic regression, adjusting also for trial centre. Similar analyses were performed to investigate the associations of age and social deprivation with AAA prevalence and with attendance at recall scans. These predictor factors were selected for investigation because information was available for almost all individuals at all stages. Age and social deprivation were considered as continuous variables in the statistical analysis, although results are presented in categories for ease of interpretation.
Social deprivation scores were derived from postcodes using the 1991 census.P:" and were available for 95% of individuals. For the purposes of analysis, the scores were ranked within 8414 wards in England. Time of year invited to attend the screening clinic was not available for 3% of nonattenders. Date invited to screening was categorised into three-month seasons (December-February as winter, and so on).
Results for initial attendance at screening are based on 31.985 individuals (95% of those randomised to be invited to screening) for whom social deprivation scores and season invited were available. Similarly, results for aneurysm prevalence are based on 25,956 individuals (96% of attenders at screening), and for attendance at recall scans on 1275 individuals (96% of those with a detected AAA).
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RESULTS
Both age and social deprivation were associated with attendance at initial screening, but season was not (Table 1) . Older men, and those in more deprived areas, were less likely to attend. There was a trend for nonattendance rates to increase across all four quartiles of social deprivation, from 15 % in the least deprived to 25% in the most deprived group.
Age and social deprivation were also associated with having an AAA amongst those attending initial screening ( Table 2 ). The AAA prevalence was about 50% greater in the older age group and in the most deprived quartile (both 6% vs 4%). Thus the subgroups least likely to attend screening were also those most likely to have an AAA.
For attendance at recall scans (Table 3) , the findings were not as statistically convincing as the previous associations, being based on the smaller number of men with a detected AAA. However attendance at follow-up was lower in the older age group, and estimates suggest there may also be lower attendance at follow-up in the more deprived social groups.
DISCUSSION
This analysis brings together predictors of attendance at screening and of AAA prevalence, and implicates social deprivation in particular as being an important determinant of both. Therefore, those who are least likely to attend for screening are those most likely to have an AAA. For example, the quartile of highest social deprivation accounts for only 23% of all attendance but for 28% of aneurysms found. Age is also implicated as a determinant of AAA prevalence and attendance at initial screening, and is weakly associated with attendance at follow-up. These results are based on a large, population-based study with little missing data, adding strength to the conclusions. The association of social class with attendance at screening has been observed in other screening programmes. 10.12. 19 Here, a ward-level index of social deprivation" was obtained for each individual according to postcode. This is a measurement of overall deprivation, comprising information from six domains: income, employment, education and skills, health and disability, housing, and access to vital services. It contrasts with other commonly used measures of socioeconomic status, which may be measures of material deprivation (such as the Townsend index and the Carstairs index) or may be based on occupational information (such as social class). Since the measure employed here is at ward level, there is inevitably some inaccuracy in using this summary data to estimate individual social deprivation. Furthermore, the centres involved in the MASS trial are less deprived (median rank 2692) than England as a whole (median rank 4207). This may have implications for a more cautious extrapolation of these results to the most deprived groups.
It is important to take measures to encourage participation in groups with lower participation and higher prevalence, in order to avoid further increasing health inequalities." Providing equal health gain across social groups may also improve the efficacy and cost-effectiveness of the screening programme;" The results of the MASS trial were achieved using invitations alone, with no additional publicity, owing to the presence of a control group in the population. However, in a national screening programme, publicity would be implemented to increase participation and may be targeted at particular groups.
In practice, increasing attendance at AAA screening amongst socially deprived groups requires a better understanding of the factors influencing their participation, such as lower knowledge or cost and transport difficulties. However, lower attendance in the more socially deprived groups may reflect a difference in values pertinent to participation that are socially patterned, such as the desire to avoid surgery. It may therefore be necessary to accept this as a legitimate reason for nonparticipation, reflecting an informed choice."
Additional factors not available for this study, such as smoking status, ethnicity, marital status, previous knowledge of the disease and convenience of screening, have all been linked with attendance at screening.IO·11. 13-16. deprivation. Another potentially important factor in attendance at screening is ethnicity.'>!" however, ethnicity is unlikely to have had an important role in the MASS trial, because only 7% of individuals in the areas covered are from nonwhite ethnic groups."
The results of this study add to the evidence for an association of age with attendance at screening. Other studies have variously reported either older or younger individuals as more likely to attend, reflecting differences in screening procedures and age coverage of particular programmes. In the current study, the population comprises older men (ages 65-74), with significantly lower attendance and significantly higher AAA prevalence observed with increasing age. The policy implications of this observation must be considered alongside evidence relating to AAA disease progression with age and the practicalities of implementing a screening programme. [31] [32] [33] In MASS, those who did not attend screening had substantially higher rates of AAA-related and all-cause mortality than those who attended, and the estimated benefit of screening was greater amongst attenders than amongst the whole group invited to attend.' In addition, some AAA-related deaths were apparently related to nonattendance at scheduled clinical follow-up.' Thus, measures to improve attendance at initial and follow-up scans should yield benefits in terms of the overall efficacy of AAA screening. This will be particularly the case for older and more deprived groups, since they have lower attendance at screening and recall, yet higher AAA prevalence. There was no evidence in MASS that either the clinical benefit or costs depended on age or level of deprivation, so targeting measures to improve attendance and compliance at older and more deprived groups should also yield the greatest benefit in terms of overall cost-effectiveness.
